Skip to main navigation
Skip to search
Skip to main content
Northwestern Scholars Home
Help & FAQ
Home
Experts
Organizations
Research Output
Grants
Core Facilities
Research Data
Search by expertise, name or affiliation
Prot#EIDOS AG10-201:A Phase 2, Randomized, Placebo-controlled, Dose-ranging Study of the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AG10 in Patients with Symptomatic Transthyretin Amyloid Cardiomyopathy
Shah, Sanjiv J
(PD/PI)
Medicine, Cardiology Division
Project
:
Research project
Overview
Project Details
Status
Finished
Effective start/end date
3/15/18
→
3/14/23
Funding
Eidos Therapeutics, Inc.
(EIDOS AG10-201)
View all
View less